Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $228.29 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $122.72 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $71.34 | 4 | $0 (2022) |
| PFIZER INC. | $34.23 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.52 | 1 | E.R. Squibb & Sons, L.L.C. ($21.52) |
| 2022 | $74.53 | 4 | E.R. Squibb & Sons, L.L.C. ($57.53) |
| 2021 | $96.43 | 6 | E.R. Squibb & Sons, L.L.C. ($43.67) |
| 2020 | $35.81 | 2 | Janssen Pharmaceuticals, Inc ($19.78) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.52 | General |
| Category: Cardiovascular | ||||||
| 10/11/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Cardiovascular | ||||||
| 05/25/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Cardiovascular | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: Cardiovascular | ||||||
| 09/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Cardiovascular | ||||||
| 04/07/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/07/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Cardiovascular | ||||||
| 02/16/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| Category: Cardiovascular | ||||||
| 12/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 712 | 757 | $986,926 | $94,014 |
| 2022 | 4 | 751 | 796 | $1.1M | $109,465 |
| 2021 | 4 | 953 | 1,005 | $1.3M | $136,694 |
| 2020 | 6 | 1,082 | 1,140 | $1.1M | $117,219 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 318 | 339 | $477,953 | $45,845 | 9.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 155 | 158 | $274,293 | $26,175 | 9.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 191 | 211 | $206,392 | $19,356 | 9.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 48 | 49 | $28,288 | $2,639 | 9.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 383 | 414 | $582,629 | $60,452 | 10.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 173 | 179 | $309,916 | $32,402 | 10.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 127 | 131 | $128,008 | $12,729 | 9.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 68 | 72 | $42,021 | $3,882 | 9.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 432 | 463 | $652,247 | $70,857 | 10.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 182 | 184 | $319,398 | $35,171 | 11.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 219 | 230 | $224,590 | $23,273 | 10.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 120 | 128 | $73,892 | $7,393 | 10.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 380 | 405 | $541,775 | $57,262 | 10.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 169 | 177 | $304,486 | $32,768 | 10.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 182 | 187 | $169,848 | $18,315 | 10.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 112 | 113 | $54,301 | $5,817 | 10.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 228 | 246 | $15,990 | $1,625 | 10.2% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 11 | 12 | $10,320 | $1,432 | 13.9% |
About Dr. Rasheed Siddiqui, M.D
Dr. Rasheed Siddiqui, M.D is a Internal Medicine healthcare provider based in Standish, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003940636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rasheed Siddiqui, M.D has received a total of $228.29 in payments from pharmaceutical and medical device companies, with $21.52 received in 2023. These payments were reported across 13 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($228.29).
As a Medicare-enrolled provider, Siddiqui has provided services to 3,498 Medicare beneficiaries, totaling 3,698 services with total Medicare billing of $457,391. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Standish, MI
- Active Since 03/15/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003940636
Products in Payments
- ELIQUIS (Drug) $118.28
- XARELTO (Drug) $71.34
- CAMZYOS (Drug) $38.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.